United States Daily Briefing

INTC's 10.6% surge to $133.99 on elevated volume is the day's most decisive single-stock move. The narrative combines AI custom silicon optimism with the Iran deal's energy-cost relief for high-electricity-intensity chip fabs. AMD confirming at +4.9% adds sector conviction — this isn't INTC-specific noise. The question for tomorrow is whether profit-takers emerge at the open or whether the catalyst is durable enough to sustain a break above key technical resistance levels.

Form 4 filings show $966.6M in insider sales against zero buys over 72 hours. Walton Family Holdings Trust sold two tranches totaling $532.7M out of WMT (3.9M shares), while Artal Participations sold 3M shares of CAVA for $270.9M. Neither trade reflects a fundamentals view change, but the $967M supply overhang with zero offsetting insider conviction buys reads as smart-money risk-reduction ahead of a volatile Fed communication period under incoming Chair Warsh.

The pharma pair's simultaneous -2.5%+ declines signal defensive-sector rotation as risk appetite returned to growth and semis. PFE at $25.21 and JNJ at $228.39 aren't company-specific stories today — it's factor rotation out of XLV into XLK. Watch whether XLV holds its 200-day moving average on the open tomorrow; a break lower confirms the rotation is structural, not just intraday repositioning.